275 related articles for article (PubMed ID: 15577575)
1. Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update.
Denison MR
Pediatr Infect Dis J; 2004 Nov; 23(11 Suppl):S207-14. PubMed ID: 15577575
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Coronavirus Virulence and Vaccine Development.
Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
[TBL] [Abstract][Full Text] [Related]
3. Animal coronavirus vaccines: lessons for SARS.
Saif LJ
Dev Biol (Basel); 2004; 119():129-40. PubMed ID: 15742624
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
5. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
[TBL] [Abstract][Full Text] [Related]
6. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
[TBL] [Abstract][Full Text] [Related]
8. Cynomolgus macaque as an animal model for severe acute respiratory syndrome.
Lawler JV; Endy TP; Hensley LE; Garrison A; Fritz EA; Lesar M; Baric RS; Kulesh DA; Norwood DA; Wasieloski LP; Ulrich MP; Slezak TR; Vitalis E; Huggins JW; Jahrling PB; Paragas J
PLoS Med; 2006 May; 3(5):e149. PubMed ID: 16605302
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.
Weiss SR; Navas-Martin S
Microbiol Mol Biol Rev; 2005 Dec; 69(4):635-64. PubMed ID: 16339739
[TBL] [Abstract][Full Text] [Related]
10. From SARS to MERS, Thrusting Coronaviruses into the Spotlight.
Song Z; Xu Y; Bao L; Zhang L; Yu P; Qu Y; Zhu H; Zhao W; Han Y; Qin C
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646565
[TBL] [Abstract][Full Text] [Related]
11. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.
Enjuanes L; Dediego ML; Alvarez E; Deming D; Sheahan T; Baric R
Virus Res; 2008 Apr; 133(1):45-62. PubMed ID: 17416434
[TBL] [Abstract][Full Text] [Related]
12. Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
Suresh MR; Bhatnagar PK; Das D
J Pharm Pharm Sci; 2008 Apr; 11(2):1s-13s. PubMed ID: 19203466
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
[TBL] [Abstract][Full Text] [Related]
14. Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.
Ng OW; Tan YJ
Hum Vaccin Immunother; 2017 Jan; 13(1):186-189. PubMed ID: 27644155
[TBL] [Abstract][Full Text] [Related]
15. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL
J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223
[TBL] [Abstract][Full Text] [Related]
16. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
17. [SARS, possible zoonosis in the area of conflict of pathogenic coronaviruses of animals].
Tobler K; Ackermann M; Griot C
Schweiz Arch Tierheilkd; 2003 Jul; 145(7):316-22. PubMed ID: 12894604
[TBL] [Abstract][Full Text] [Related]
18. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates.
Wu D; Tu C; Xin C; Xuan H; Meng Q; Liu Y; Yu Y; Guan Y; Jiang Y; Yin X; Crameri G; Wang M; Li C; Liu S; Liao M; Feng L; Xiang H; Sun J; Chen J; Sun Y; Gu S; Liu N; Fu D; Eaton BT; Wang LF; Kong X
J Virol; 2005 Feb; 79(4):2620-5. PubMed ID: 15681462
[TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D
Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
[TBL] [Abstract][Full Text] [Related]
20. Vaccine design for severe acute respiratory syndrome coronavirus.
He Y; Jiang S
Viral Immunol; 2005; 18(2):327-32. PubMed ID: 16035944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
